Bioventus Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Bioventus Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q1 2021 to Q2 2024.
  • Bioventus Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending June 29, 2024 was $189M, a 19% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $189M -$44.3M -19% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $217M -$22.9M -9.54% Mar 30, 2024 10-Q 2024-08-06
Q4 2023 $221M -$191M -46.4% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $226M -$225M -49.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $233M -$359M -60.6% Jul 1, 2023 10-Q 2024-08-06
Q1 2023 $240M -$353M -59.5% Apr 1, 2023 10-Q 2024-08-06
Q4 2022 $412M -$195M -32.2% Dec 31, 2022 10-Q 2024-08-06
Q3 2022 $451M +$221M +95.7% Oct 1, 2022 10-Q 2023-11-07
Q2 2022 $592M +$373M +170% Jul 2, 2022 10-Q 2023-11-07
Q1 2022 $594M +$374M +170% Apr 2, 2022 10-Q 2023-08-08
Q4 2021 $608M Dec 31, 2021 10-K 2024-03-12
Q3 2021 $230M Oct 2, 2021 10-Q 2022-11-21
Q2 2021 $219M Jul 3, 2021 10-Q 2022-11-21
Q1 2021 $220M Apr 3, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.